Indoor microbiome and risk of lower respiratory tract infections among children under-five years: A meta-analysis

Adekunle G Fakunle1,2, Nkosana Jafta1, Akinkunmi P Okekunle3,4

  • 1Discipline of Occupational and Environmental Health, University of KwaZulu-Natal, Durban, South Africa.

Indoor Air
|May 29, 2020
PubMed

Insights

Exposure to indoor microbiome (IM) increases the risk of lower respiratory tract infections (LRTI) in young children. Higher fungal concentrations pose a greater risk, suggesting interventions for IM exposure are crucial for managing LRTI.

Area of Science:

  • Environmental Health
  • Pediatric Infectious Diseases
  • Microbiology

Background:

  • Indoor environments harbor diverse microbiomes.
  • Exposure to indoor microbiome (IM) is a potential risk factor for respiratory illnesses in children.
  • Lower respiratory tract infections (LRTI) are a significant cause of morbidity in children under five.

Purpose of the Study:

  • To investigate the association between indoor microbiome exposure and the risk of LRTI in children under five.
  • To conduct a meta-analysis of existing studies quantifying this relationship.

Main Methods:

  • A systematic literature search was performed across multiple electronic databases (PubMed, Scopus, Web of Science, GreenFILE, EMBASE, Cochrane Library) up to July 2019.
  • Eligible studies reported adjusted risk measures (RR or OR with CI) for LRTI associated with IM exposure.
  • A meta-analysis pooled the odds ratios (OR) using the inverse of variance method, with sensitivity and heterogeneity analyses.

Main Results:

  • Seven studies were included in the meta-analysis.
  • Higher concentrations of indoor microbiome were significantly associated with an increased risk of LRTI (OR: 1.20, P < .0001).
  • Exposure to total fungal concentration showed a stronger association with LRTI risk (OR: 1.27, P < .0001) compared to visible molds (OR: 1.20, P = .001).

Conclusions:

  • Children under five exposed to higher indoor microbiome concentrations are at increased risk of developing LRTI.
  • Interventions aimed at reducing indoor microbiome exposure should be considered in the prevention and management of LRTI in young children.

Related Concept Videos

Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.2K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
799